Insiders · RANI

RANI insider transactions

Rani Therapeutics Holdings Inc. (RANI) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for RANI

• 29d
  SEC Form 3 filed by new insider Javadi Alireza

  3 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 177d
  SEC Form 4 filed by Director Bailey Vasudev Jaiprakash

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 177d
  SEC Form 3 filed by new insider Bailey Vasudev Jaiprakash

  3 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 180d
  SEC Form 4 filed by Director Bassan Abraham

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 180d
  SEC Form 3 filed by new insider Bassan Abraham

  3 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 180d
  Director Imran Mir A bought $1,260,417 worth of shares (2,083,334 units at $0.60) (SEC Form 4)

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 185d
  Large owner South Cone Investments Limited Partnership sold $15,711,314 worth of shares (5,923,000 units at $2.65) (SEC Form 4)

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 263d
  SEC Form 4 filed by Chief Business Officer Mckinley Kate

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 330d
  SEC Form 4 filed by Director Nanavaty Maulik

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 330d
  SEC Form 4 filed by Director Imran Mir A

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 330d
  SEC Form 4 filed by Director Rometty Lisa Ann

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 330d
  SEC Form 4 filed by Director Butel Jean Luc

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 330d
  SEC Form 4 filed by Director Ausiello Dennis A

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 330d
  SEC Form 4 filed by Director Farquharson Andrew

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 337d
  SEC Form 4 filed by Chief Scientific Officer Hashim Mir

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 337d
  SEC Form 4 filed by Chief Business Officer Mckinley Kate

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 337d
  SEC Form 4 filed by Chief Executive Officer Imran Talat

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 337d
  SEC Form 4 filed by Chief Financial Officer Sanford Svai S

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 494d
  SEC Form 4 filed by Director Rometty Lisa Ann

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 494d
  SEC Form 4 filed by Director Debuono Laureen

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 494d
  SEC Form 4 filed by Director Farquharson Andrew

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 494d
  SEC Form 4 filed by Director Ausiello Dennis A

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 494d
  SEC Form 4 filed by Director Butel Jean Luc

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 494d
  SEC Form 4 filed by Director Imran Mir A

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 494d
  SEC Form 4 filed by Director Nanavaty Maulik

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 495d
  Chief Business Officer Mckinley Kate bought $29,993 worth of shares (17,960 units at $1.67) (SEC Form 4)

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 501d
  Chief Executive Officer Imran Talat bought $19,974 worth of shares (10,296 units at $1.94), increasing direct ownership by 2% to 494,751 units (SEC Form 4)

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 555d
  Large owner South Cone Investments Limited Partnership sold $10,141,674 worth of shares (3,829,360 units at $2.65) (SEC Form 4)

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 695d
  SEC Form 4 filed by Imran Mir A

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 695d
  SEC Form 4 filed by Butel Jean Luc

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 695d
  SEC Form 4 filed by Rometty Lisa Ann

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 695d
  SEC Form 4 filed by Debuono Laureen

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 695d
  SEC Form 4 filed by Nanavaty Maulik

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 695d
  SEC Form 4 filed by Farquharson Andrew

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 695d
  SEC Form 4 filed by Ausiello Dennis A

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 764d
  SEC Form 4 filed by Mckinley Kate

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 764d
  SEC Form 4 filed by Hashim Mir

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 764d
  SEC Form 4 filed by Groen Eric

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 764d
  SEC Form 4 filed by Imran Talat

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 764d
  SEC Form 4 filed by Sanford Svai S

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 858d
  SEC Form 4 filed by Hashim Mir

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 858d
  SEC Form 4 filed by Sanford Svai S

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 858d
  SEC Form 4 filed by Imran Talat

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 858d
  SEC Form 4 filed by Ausiello Dennis A

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 858d
  SEC Form 4 filed by Groen Eric

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 858d
  SEC Form 4 filed by Butel Jean Luc

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 858d
  SEC Form 4 filed by Nanavaty Maulik

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 858d
  SEC Form 4 filed by Debuono Laureen

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 858d
  SEC Form 4 filed by Farquharson Andrew

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 858d
  SEC Form 4 filed by Mckinley Kate

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 858d
  SEC Form 4 filed by Rometty Lisa Ann

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 858d
  SEC Form 4 filed by Imran Mir A

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 869d
  Quiroga Cortes Isidoro Alfonso sold $10,582,982 worth of shares (5,265,165 units at $2.01) (SEC Form 4)

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 869d
  South Cone Investments Limited Partnership bought $10,582,982 worth of shares (5,265,165 units at $2.01) (SEC Form 4)

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 870d
  Imran Talat bought $22,700 worth of shares (10,000 units at $2.27), increasing direct ownership by 2% to 484,455 units (SEC Form 4)

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 871d
  Imran Talat bought $12,850 worth of shares (5,000 units at $2.57), increasing direct ownership by 1% to 474,455 units (SEC Form 4)

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 876d
  Imran Talat bought $41,000 worth of shares (20,000 units at $2.05), increasing direct ownership by 4% to 469,455 units (SEC Form 4)

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 886d
  Butel Jean Luc bought $102,495 worth of shares (50,500 units at $2.03) (SEC Form 4)

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 887d
  Nanavaty Maulik bought $990 worth of shares (500 units at $1.98) (SEC Form 4)

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)
• 898d
  Imran Talat bought $9,975 worth of shares (5,000 units at $2.00), increasing direct ownership by 1% to 449,455 units (SEC Form 4)

  4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)